Latest news
IMR: U.S. launch, regulatory wins, and new verticals set stage for accelerated growth in 2H 2026 - TradingViewTradingView · Sun, 09 Aug 2026 23:52:12 GMTIMR: Four FDA clearances, U.S. launch, and strong cash position set stage for growth in 2H26 - TradingViewTradingView · Sun, 09 Aug 2026 23:01:34 GMTIMR: U.S. commercial launch and regulatory wins set stage for growth despite lower Q2 revenue - TradingViewTradingView · Sun, 09 Aug 2026 23:00:52 GMTIMR: U.S. launch, regulatory wins, and new verticals set stage for revenue inflection and growth - TradingViewTradingView · Sun, 09 Aug 2026 00:42:00 GMTAC Immune SA Revenue Breakdown – HAM:IMR - TradingViewTradingView · Fri, 31 Jul 2026 18:24:31 GMT